We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Cellular Digital Fibroma: A Comprehensive Review of a CD34-Positive Acral Lesion of the Distal Fingers and Toes

    Cellular digital fibroma is a benign fibrous lesion that typically occurred on either a finger or a toe. Cellular digital fibroma was introduced as a...

    Philip R. Cohen, Robert S. Alpert, Antoanella Calame in Dermatology and Therapy
    Article Open access 29 July 2020
  2. Characteristics of cells with engraftment capacity within CD34+ cell population upon G-CSF and Plerixafor mobilization

    In the context of hematopoietic cell transplantation, hematopoietic stem cells and progenitor cells (HSC and HPC) are usually collected by apheresis...

    Margaux Mombled, Laura Rodriguez, ... Philippe Brunet de la Grange in Leukemia
    Article 20 July 2020
  3. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin

    Double unit cord blood (dCB) transplantation (dCBT) is associated with high engraftment rates but delayed myeloid recovery. We investigated adding...

    Ioannis Politikos, Sean M. Devlin, ... Juliet N. Barker in Leukemia
    Article 18 June 2020
  4. High mobilization of CD133+/CD34+ cells expressing HIF-1α and SDF-1α in septic abdominal surgical patients

    Background

    The control of endothelial progenitor cells (CD133+/CD34+ EPCs) migrating from bone marrow to peripheral blood is not completely...

    Antonella Cotoia, Olga Cela, ... Gilda Cinnella in BMC Anesthesiology
    Article Open access 27 June 2020
  5. Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC

    Cytopenia is a well-documented complication in the treatment of hematological malignancies with lenalidomide and pomalidomide. Although prior studies...

    Sumie Fujii, Yasuo Miura in International Journal of Hematology
    Article Open access 12 July 2024
  6. Proportion of CD34+CD38−CD123+ Leukemia Stem Cells at Diagnosis Varies in ELN Risk Groups and an Emerging Novel Marker for Prognosticating the Intermediate Risk patients of Acute Myeloid Leukemia: A Prospective Study

    The proportion of CD34  +  CD38  −  CD123  + leukemia stem cells (LSCs) at diagnosis of Acute Myeloid Leukemia (AML) correlated with induction remission...

    Priyanka Mishra, Seema Tyagi, ... Manoranjan Mahapatra in Indian Journal of Hematology and Blood Transfusion
    Article 03 January 2021
  7. Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification

    The percentage of blasts cells in the bone marrow (BM) of MDS patients is one of the key parameters for MDS classification and for the differential...

    Leonie Saft, Botond Timar, Anna Porwit in Journal of Hematopathology
    Article Open access 23 April 2020
  8. Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells

    Myelodysplastic neoplasms (MDS) encompass haematological malignancies, which are characterised by dysplasia, ineffective haematopoiesis and the risk...

    Margot F. van Spronsen, Sofie Van Gassen, ... Arjan A. van de Loosdrecht in Leukemia
    Article Open access 08 March 2024
  9. Medium supplementation can influence the human ovarian cells in vitro

    Background

    Cells are an essential part of the triple principles of tissue engineering and a crucial component of the engineered ovary as they can...

    Arezoo Dadashzadeh, Saeid Moghassemi, ... Christiani A. Amorim in Journal of Ovarian Research
    Article Open access 26 December 2022
  10. Expression of CD34, PCNA and VEGF in CIN-3 and Invasive Squamous Cell Carcinoma Cervix: A Pilot Study

    Purpose

    Although the role of classical (clinico-pathological features) and modern prognostic factors (immune biomarkers) has been described in...

    Nidhi Jais-Sahu, Abhay V. Deshmukh, Nitin M. Gangane in Indian Journal of Gynecologic Oncology
    Article 28 May 2020
  11. Development and validation of a predictive model to guide the use of plerixafor in pediatric population

    Plerixafor, a CXCR4 receptor antagonist, reduces the binding and chemotaxis of hematopoietic stem cells to the bone marrow stroma, resulting in...

    Bernard Sebastien, Peter Cheverton, ... Remi Castan in Bone Marrow Transplantation
    Article Open access 26 September 2022
  12. Chronic Sclerosing Sialadenitis of the Submandibular Gland and its Histopathological Spectrum in the IgG4-Related Disease: a Series of 17 Cases

    Purpose

    This study aimed to characterize the histopathological immunohistochemical features of chronic sclerosing sialadenitis, emphasizing the...

    Vinícius Rio Verde Melo Muniz, Albina Altemani, ... Jean Nunes dos Santos in Head and Neck Pathology
    Article 13 May 2024
  13. Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization

    High-dose cyclophosphamide (HD-Cy) (3 g/m 2 ) plus granulocyte colony-stimulating factor (G-CSF) is a very effective regimen for peripheral blood stem...

    Li-qiong Hou, Jun-Ru Liu, ... Juan Li in Annals of Hematology
    Article Open access 25 January 2024
  14. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial

    Background

    Endothelial Progenitor cells (EPCs) has been shown to be dysfunctional in both type 2 diabetes mellitus (T2DM) and chronic kidney disease...

    Hassan B. Awal, Seshagiri Rao Nandula, ... Sabyasachi Sen in Cardiovascular Diabetology
    Article Open access 03 June 2020
  15. Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors

    A single injection of 12 mg pegfilgrastim was used to mobilize peripheral blood progenitor cells (PBPCs) from healthy donors in some studies. The...

    Junjie Cao, Aizhen Li, ... Peipei Ye in Annals of Hematology
    Article 29 September 2023
  16. Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients

    Separase, a cysteine endopeptidase, is a key player in mitotic sister chromatid separation, replication fork dynamics, and DNA repair. Aberrant...

    Birgit Spiess, Helga Kleiner, ... Wolfgang Seifarth in Annals of Hematology
    Article Open access 06 April 2020
  17. Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

    To define the tolerability and outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) following CAR T-cell therapy, we retrospectively...

    Vanessa A. Fabrizio, Nancy A. Kernan, ... Kevin J. Curran in Bone Marrow Transplantation
    Article 10 May 2020
  18. Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia

    Immune thrombocytopenia (ITP) is an autoimmune disorder, in which megakaryocyte dysfunction caused by an autoimmune reaction can lead to...

    Yan Liu, **nyi Zuo, ... Jun Peng in Signal Transduction and Targeted Therapy
    Article Open access 07 October 2022
Did you find what you were looking for? Share feedback.